Trial Profile
Contrast-Enhanced Ultrasound Evaluation of Bowel Wall Inflammation in Pediatric Crohn's Disease: Comparison to CT and MRI Enterography
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2023
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Crohn's disease
- Focus Diagnostic use
- 26 Sep 2023 Planned End Date changed from 1 Jan 2024 to 1 Jan 2025.
- 26 Sep 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Feb 2024.
- 22 Jul 2022 Planned End Date changed from 1 Jun 2022 to 1 Jan 2024.